NCT04908397View on ClinicalTrials.gov

Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 29, 2021

Primary Completion Date

June 1, 2023

Study Completion Date

June 30, 2023

Conditions
Pulmonary Arterial HypertensionFamilial Primary Pulmonary HypertensionPrimary Pulmonary HypertensionLung DiseasesCarnitine Nutritional Deficiency
Interventions
DIETARY_SUPPLEMENT

L-carnitine

supplement provided twice a day for 2 weeks

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT04908397 - Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter